logo
Scientists Struggle to Communicate With 2 Spacecraft Launched Wednesday

Scientists Struggle to Communicate With 2 Spacecraft Launched Wednesday

Yahoo03-03-2025

Scientists are struggling to maintain contact with not one, but two spacecraft launched alongside a new commercial lunar lander on Wednesday. NASA's Lunar Trailblazer, which aims to map the Moon's water cycle, and AstroForge's Odin, which will analyze an asteroid's potential metal content, have both failed to transmit consistent data to their teams on the ground, leading to concerns about their respective missions.
Since day one, Lunar Trailblazer has had quite the journey ahead of it: The satellite's meandering yet fuel-efficient path toward lunar orbit is set to take four months. A few hours after the spacecraft's launch last week, NASA reported that Lunar Trailblazer had powered up as planned and successfully sent a radio signal to the agency's Deep Space Network Canberra complex in Australia. A day later, however, NASA shared that mission operators had lost communication with the spacecraft in the wee hours of morning.
Lunar Trailblazer had reportedly transmitted telemetry data indicating intermittent power system issues shortly before the communication disruption. Hours later, the spacecraft turned on its transmitter, allowing operators to begin reestablishing contact. They're now working to assess the satellite's self-reported power issues, according to NASA's latest statement.
Odin has traveled an even rockier road, and not because it's looking for asteroids. A day after launch, AstroForge, the "asteroid mining" firm behind the spacecraft, shared via X that it had experienced "countless ground station issues" but had communicated with Odin on several occasions. Early the following morning—roughly 36 hours after launch—the team noted in a video update that they had received carrier signals from Odin, but no telemetry. Still, they assumed the spacecraft was in a power-positive state and remained hopeful that the communication issues were on the ground, not with Odin itself.
Finally, in a written update published Saturday, AstroForge shared that a polarization issue with Odin's antenna prevented both uplink and downlink for the first four hours of the mission—a critical loss for any spacecraft, due to the system checks and critical maneuvers required during that window. It took the amateur satellite network AmSat accidentally stumbling upon Odin's signal to reestablish communication between AstroForge and its spacecraft. Still, the back-and-forth has been shaky, and AstroForge has been spending the last few days scrambling to reduce interference as Odin continues what is thought to be a "really slow, uncontrolled tumble" through space.
Both spacecraft launched from Kennedy Space Center via SpaceX's Falcon 9 rocket on Feb. 26. They hitched a ride with Athena, a lunar lander from the Texas-based aerospace firm Intuitive Machines. As far as we know, Athena is the only spacecraft of the trio not to have experienced communication issues so far; in fact, it's beamed down some gorgeous snapshots of Earth ahead of its landing attempt on March 6.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China robotaxis, Indian pharma among hedge fund top picks at Sohn Hong Kong
China robotaxis, Indian pharma among hedge fund top picks at Sohn Hong Kong

Yahoo

time21 minutes ago

  • Yahoo

China robotaxis, Indian pharma among hedge fund top picks at Sohn Hong Kong

By Summer Zhen HONG KONG (Reuters) -Hedge funds revealed their top investment ideas, ranging from Chinese self-driving taxis, an Indian drug retailer, to a Korean nuclear plant builder, at the annual Sohn investment conference in Hong Kong. This year's picks are geographically more diverse compared to last year, suggesting that investors are actively seeking to spread their exposure to counter tariff uncertainties and market volatility. San Francisco-based Flight Deck Capital sees upside potential in Chinese search engine giant Baidu, betting on its fast-growing auto-driving business. Similar to Google's self-driving unit Waymo, Baidu's Apollo Go "is the only robo-taxi player in China that's not dependent on the capital markets to scale," Flight Deck founder and managing partner Jay Kahn said at the conference on Friday. He expects China's taxi and ride-share industry to grow to around $237 billion by 2034, with Apollo taking a 15% market share. But that segment, together with Baidu's cloud business, is currently given zero valuation by the market, he said. Notably, investor optimism on Chinese firms going overseas has not been derailed by the escalating U.S.-China trade war. Hong Kong's Apeiron Capital pitched Chinese ride-hailing company DiDi Global, citing its improving margin at home and its quick market share building in Latin America. Meanwhile Triata Capital is upbeat on Chinese discount e-commerce player PDD, the owner of Temu. "One statistic that a lot of people don't know is that their MAU right now is bigger than Amazon," Triata CIO Sean Ho said, referring to Temu's monthly active users. INDIA Two investors set their sights on India's healthcare space. Singapore's Arisaig Partners favors MedPlus Health Services, a leading pharmacy chain in India, as its private label products strengthen its low-price proposition, widening the gap with competitors. "Inflation is lower, government is focusing on the middle class and consumer spending is coming off a low base. I simply believe this is the time when the consumer space in general will do better," Vatsal Mody, partner and head of India research at Arisaig Partners said in an interview ahead of the conference. India-based hedge fund startup Panvira Management is bullish on Piramal Pharma, a contract development and manufacturing organisation (CDMO), expecting its growth to accelerate to high teens and to benefit from tax rate normalisation. SECURITY AND ACTIVISTS Other emerging hedge funds focused on opportunities in the security sector driven by geopolitical conflicts. Jon Jhun, who manages Management's new Korea-focused fund, chose Hyundai Engineering & Construction, which engages in nuclear plant engineering, procurement and construction (EPC). "Korea dominates the ex-Russia, ex-China nuclear supply chain," he said. Hong Kong's Frontline Global Management picked Spanish defence firm Indra Sistemas, believing the firm will win more European contracts. On the activist investor side, UK hedge fund Palliser Capital disclosed a 3% stake in Japan's Toyo Tire at the event, urging the tire maker to boost shareholder returns by setting a "best-in-class" performance target and releasing its excess capital of about $900 million to shareholders. Seth Fischer's Oasis Management is long Japanese entertainment complex chain Round One, betting it will gain a re-rating as it ventures into the restaurant industry aiming to bring Michelin-quality Japanese food to the U.S. Sign in to access your portfolio

AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI
AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI

Business Insider

time24 minutes ago

  • Business Insider

AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI

Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca's (AZN) IMFINZI in combination with standard-of-care FLOT chemotherapy demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of event-free survival, EFS, versus chemotherapy alone. Patients were treated with neoadjuvant IMFINZI in combination with chemotherapy before surgery, followed by adjuvant IMFINZI in combination with chemotherapy, then IMFINZI monotherapy. The trial evaluated this regimen versus perioperative chemotherapy alone for patients with resectable, early-stage and locally advanced gastric and gastroesophageal junction, GEJ, cancers. In a planned interim analysis, patients treated with the IMFINZI-based perioperative regimen showed a 29% reduction in the risk of disease progression, recurrence or death versus chemotherapy alone. Estimated median EFS was not yet reached for the IMFINZI arm versus 32.8 months for the comparator arm. For the secondary endpoint of overall survival, a strong trend was observed in favor of the IMFINZI-based perioperative regimen. The trial will continue to follow OS, which will be formally assessed at the final analysis. Confident Investing Starts Here:

Guardant Health presented results of largest study on ctDNA in colon cancer
Guardant Health presented results of largest study on ctDNA in colon cancer

Business Insider

time24 minutes ago

  • Business Insider

Guardant Health presented results of largest study on ctDNA in colon cancer

Guardant Health (GH) presented results of the largest study to date evaluating circulating tumor DNA, ctDNA, in colon cancer prior to chemotherapy, demonstrating the ability of the Guardant Reveal test to stratify the risk of disease recurrence and overall survival, and thus inform treatment decisions after surgery. Data from the phase III trial of FOLFOX-based adjuvant chemotherapy involving over 2,000 patients with stage III colon cancer with median follow-up of 6.1 years were presented at the 2025 American Society for Clinical Oncology Annual Meeting. Results demonstrated that circulating tumor DNA detected in the bloodstream after cancer surgery and prior to the start of adjuvant therapy, using the Guardant Reveal test, is a strong predictor of the risk of disease recurrence and poorer survival, and suggest the potential for ctDNA testing to improve decision-making at a critical time point for post-operative chemotherapy. Specifically: Among patients with post-surgical ctDNA detected, 62.6% had the cancer return within 3 years, despite having had adjuvant chemotherapy, while only 15.4% of patients with undetectable ctDNA recurred in the same period. The level of ctDNA, or tumor fraction, showed promise in identifying individuals who are less likely to clear residual disease with adjuvant treatment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store